Navigation Links
New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA)
Date:11/9/2010

se disorders.

Hematologic ReactionsRare reports of pancytopenia, including aplastic anemia, have been reported with TNF blockers. Medically significant cytopenia (e.g., leukopenia, pancytopenia, thrombocytopenia) has been infrequently reported with certolizumab pegol.  Advise all patients to seek immediate medical attention if they develop signs and symptoms suggestive of blood dyscrasias or infection (e.g., persistent fever, bruising, bleeding, pallor) while on certolizumab pegol.  Consider discontinuation of certolizumab pegol therapy in patients with confirmed significant hematologic abnormalities.

Drug InteractionsAn increased risk of serious infections has been seen in clinical trials of other TNF blocking agents used in combination with anakinra or abatacept.  Formal drug interaction studies have not been performed with rituximab or natalizumab; however because of the nature of the adverse events seen with these combinations with TNF blocker therapy, similar toxicities may also result from the use of certolizumab pegol in these combinations.  Therefore, the combination of certolizumab pegol with anakinra, abatacept, rituximab, or natalizumab is not recommended.  Interference with certain coagulation assays has been detected in patients treated with certolizumab pegol.  There is no evidence that certolizumab pegol therapy has an effect on in vivo coagulation.  Certolizumab pegol may cause erroneously elevated aPTT assay results in patients without coagulation abnormalities.

AutoimmunityTreatment with certolizumab pegol may result in the formation of autoantibodies and, rarely, in the development of a lupus-like syndrome.  Discontinue treatment if symptoms of lupus-like syndrome develop.

ImmunizationsDo not administer live vaccines or attenuated vaccines concurrently with certolizumab pegol.

Adverse Reactions'/>"/>

SOURCE UCB
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Rapid and Long-term Clinical Responses Observed in Rheumatoid Arthritis Patients Taking Cimzia® (certolizumab pegol), According to Data Being Highlighted During ACR Meeting
2. UCB Presents Growing Body of Long-term Efficacy Data at ACG 2010 Meeting to Further Support Treatment with Cimzia® (certolizumab pegol) in Multiple Patient Populations with Moderate to Severe Crohns Disease
3. Long-Term Data on Cimzia® (certolizumab pegol) for Moderate to Severe Crohns Disease to be Highlighted at ACG Meeting
4. New Data Show CIMZIA(R) (certolizumab pegol) Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients
5. CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years
6. CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohns Disease Patients
7. CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohns Patients
8. CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year
9. Marken Rapidly Responds to Global Supply Chain Security Measures
10. Biosimilar Erosion of Branded ESA Market Share Will be More Rapid in the U.S. Than in Europe
11. Results of Boehringer Ingelheim Oral Hepatitis C Protease Inhibitor and Polymerase Inhibitor Combination Phase Ib Trial Shows Rapid Viral Response Without Use of Pegylated Interferon
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... -- Research and Markets has announced ... (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - ... On the basis of type ... been divided into eight major segments, namely, light/laser, ... ablation technologies. The light/laser ablation technology segment accounted ...
(Date:9/22/2014)... 22, 2014  Olympus, a global technology leader ... and surgical procedures, among other core businesses, announced ... Munich -based Brainlab to be the ... This agreement applies to the US ENT market; ... and all distribution outside the U.S. The system, ...
(Date:9/22/2014)... 2014  Sutro Biopharma today announced that it has ... 2014,s Fierce 15 biotechnology companies, designating it as one ... industry.  "Sutro has earned some careful ... as industry partners for what promises to be a ... John Carroll , editor of FierceBiotech .  ...
Breaking Medicine Technology:Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 2Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 3Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 2Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 3Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 4FierceBiotech names Sutro Biopharma as one of its "Fierce 15" Biotech Companies of 2014 2FierceBiotech names Sutro Biopharma as one of its "Fierce 15" Biotech Companies of 2014 3
... 5 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: ... China , announced today that it,will release its financial results for ... of the market on Monday, August 16, 2010 . The ... at 8:00 a.m. ET to review,the Company,s financial ...
... Advanced Brain Technologies today announced results demonstrating that a modified ... Down syndrome. The results of the study, conducted in Nottingham, United ... of the article scheduled to appear in the journal Music and Medicine(i). ... It ...
Cached Medicine Technology:Sinovac to Host Conference Call to Report Second Quarter 2010 Financial Results 2Sinovac to Host Conference Call to Report Second Quarter 2010 Financial Results 3Results of Pilot Study Published in Journal Music and Medicine Reveal The Listening Program Helps Children With Down Syndrome Improve Speech Skills 2Results of Pilot Study Published in Journal Music and Medicine Reveal The Listening Program Helps Children With Down Syndrome Improve Speech Skills 3
(Date:9/22/2014)... Alan Mozes HealthDay Reporter ... take note: Many American parents are aware of online physician-rating ... a pediatrician for their children, according to a new national ... than 1,600 parents -- further suggest that negative online ratings ... doctor has been recommended by a neighbor. Conversely, a ...
(Date:9/22/2014)... South Asians living in Canada have a higher rate ... compared with while people, McMaster researchers have found. ... Canadian Medical Association Journal (CMAJ Open) and may ... the fastest-growing ethnic groups in the country is the ... Canada, comprising about three percent of the population. They ...
(Date:9/22/2014)... 22, 2014. Kessler researchers have published a pilot ... wellness program in people with multiple sclerosis (MS). ... health, perceived stress, and pain. "Development and ... living with MS: Description and outcomes" was epublished ... International Journal of MS Care (doi: ...
(Date:9/22/2014)... 22, 2014 (HealthDay News) -- Two new prescription devices ... may provide some relief for people with migraine headaches ... new study. One device -- the Cefaly -- ... -- the Cerena -- is meant to be used ... release. "Patients have been looking for alternative migraine ...
(Date:9/22/2014)... weather can occur with little warning, so it’s important to be ... Month, Amica Insurance is offering the following tips to ... , Build an emergency supply kit. It should contain first-aid ... per person per day for at least 72 hours. , ... your family knows what to do and where to go if ...
Breaking Medicine News(10 mins):Health News:Many Parents Use Online Ratings to Pick a Pediatrician, Study Finds 2Health News:Many Parents Use Online Ratings to Pick a Pediatrician, Study Finds 3Health News:Higher risk of heart disease for South Asians in Canada 2Health News:Noninvasive Devices May Help Migraines, FDA Says 2Health News:Amica Shares Tips for National Preparedness Month 2
... UK after a successful bypass surgery in Delhi at a ... tourism.// ,Mavis Childs, 67, waited for more than two ... (NHS). But she opted for India when the operation was ... ,Childs, based in Wombourne, near Wolverhampton, says she traveled ...
... In a startling discovery, researchers have found that more ... several species that are popular pets. // , ... on Nov. 16), revealed that the symptoms like pain ... to the bacteria that thrive on bits of meat ...
... known as Kyolic may decrease the risk of heart ... to UK scientists.// ,Dr. Khalid Rhaman and colleagues ... supplementation of Kyolic brand aged garlic extract inhibits platelet ... blood clots. Clot formation inside healthy blood vessels is ...
... Another plant extract called Forskolin has been found to be ... cells in cultures and mice by up to 90 percent.// ... coleus forskohlii, a native of India that is used as ... plant in the US., ,CML, a malignant cancer of ...
... and Industry magazine says that tropical plants imported from ... and other related illnesses. // ,The Asian tiger ... this species was detected in the Netherlands leading to ... mosquitoes were detected in imported bamboo in a greenhouse ...
... some kinds of live mutated viruses can cure tumors in ... of Glasgow treated a patient with an aggressive //form of ... New Scientist reported. ,A mutation of the herpes virus ... four months to live in 1997. But, eight years later ...
Cached Medicine News:Health News:British Grandmother has timely bypass surgery in India 2Health News:More Lizards, Including Pets, Found Venomous 2Health News:Chronic Myelogenous Leukemia (CML) Has An Answer Now! 2Health News:Chronic Myelogenous Leukemia (CML) Has An Answer Now! 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: